{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T05:09:33Z","timestamp":1692335373504},"reference-count":37,"publisher":"AACN Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,1]]},"abstract":"<jats:p>Prostacyclins are a high-risk category of continuous intravenous infusions increasingly used in hospitals to treat advanced pulmonary arterial hypertension, a rare condition characterized by vasoconstriction and vascular proliferation of the pulmonary arteries. Prostacyclins are given in doses of nanograms per kilogram per minute and have a narrow therapeutic dosing range for each patient. Sudden increases or decreases in dose can be life threatening. Previous studies revealed errors in the administration of these high-risk infusions, which in some instances led to serious adverse events, including death. The literature was reviewed for safety measures in administration of high-risk intravenous medications and input was obtained from leading experts in pulmonary arterial hypertension to create a set of safety recommendations for infusion of prostacyclins.<\/jats:p>","DOI":"10.4037\/ccn2013608","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T09:44:55Z","timestamp":1380620695000},"page":"32-39","source":"Crossref","is-referenced-by-count":7,"title":["Safety Recommendations for Administering Intravenous Prostacyclins in the Hospital"],"prefix":"10.4037","volume":"33","author":[{"given":"Martha S.","family":"Kingman","sequence":"first","affiliation":[{"name":"Martha S. Kingman is a nurse practitioner in the pulmonary hypertension program at University of Texas Southwestern Medical Center, Dallas, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Chin","sequence":"additional","affiliation":[{"name":"Kelly Chin is the director of the pulmonary hypertension program at University of Texas Southwestern Medical Center at Dallas."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2471","reference":[{"key":"2019112612102186900_b1-0330032","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1378\/chest.06-2674","article-title":"Medical therapy for pulmonary arterial hypertension","volume":"131","author":"Badesch","year":"2007","journal-title":"Chest"},{"issue":"17","key":"2019112612102186900_b2-0330032","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","article-title":"ACCF\/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc; and the Pulmonary Hypertension Association","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2019112612102186900_b3-0330032","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N Engl J Med"},{"key":"2019112612102186900_b4-0330032","volume-title":"Remodulin (treprostinil) Injection [package insert]","year":"2011"},{"key":"2019112612102186900_b5-0330032","volume-title":"Veletri (epoprostenol) for Injection [package insert]","year":"2011"},{"key":"2019112612102186900_b6-0330032","volume-title":"Flolan (epoprostenol sodium) for Injection [package insert]","year":"2011"},{"issue":"4 Meeting Abstracts","key":"2019112612102186900_b7-0330032","doi-asserted-by":"crossref","first-page":"631a","DOI":"10.1378\/chest.132.4_MeetingAbstracts.631a","article-title":"REVEAL Registry: medical history and time to diagnosis of enrolled patients [abstract]","volume":"132","author":"Elliott","year":"2007","journal-title":"Chest"},{"key":"2019112612102186900_b8-0330032","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1152\/jappl.1996.80.1.191","article-title":"Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2","volume":"80","author":"Cuiper","year":"1996","journal-title":"J Appl Physiol"},{"key":"2019112612102186900_b9-0330032","unstructured":"Agency for Healthcare Research and Quality. Reducing and preventing adverse drug events to decrease hospital costs: research in action. Issue 1. Publication No. 01-0020. http:\/\/www.ahrq.gov\/research\/findings\/factsheets\/errors-safety\/aderia\/index.html. Published March 2001. Accessed July 5, 2013."},{"issue":"2","key":"2019112612102186900_b10-0330032","first-page":"24","article-title":"Frequency and type of errors and near errors reported by critical care nurses","volume":"38","author":"Balas","year":"2006","journal-title":"Can J Nurs Res"},{"issue":"8","key":"2019112612102186900_b11-0330032","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/01.CCM.0000171609.91035.BD","article-title":"The Critical Care Safety Study: the incidence and nature of adverse events and serious medical errors in intensive care","volume":"33","author":"Rothschild","year":"2005","journal-title":"Crit Care Med"},{"key":"2019112612102186900_b12-0330032","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/00003246-199708000-00014","article-title":"Preventable adverse drug events in hospitalized patients: a comparative study of intensive care units and general care units","volume":"25","author":"Cullen","year":"1997","journal-title":"Crit Care Med"},{"key":"2019112612102186900_b13-0330032","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.CCM.0000108876.12846.B7","article-title":"Medication errors involving continuously infused medications in a surgical intensive care unit","volume":"32","author":"Herout","year":"2004","journal-title":"Crit Care Med"},{"key":"2019112612102186900_b14-0330032","volume-title":"Summary of Information Submitted to MEDMARX in the Year 2002: The Quest for Quality","author":"Hicks","year":"2003"},{"key":"2019112612102186900_b15-0330032","first-page":"131","article-title":"Quantitative and qualitative analysis of medication errors: the New York experience","volume-title":"Advances in Patient Safety: From Research to Implementation. Vol 1: Research Findings","author":"Duthie","year":"2005"},{"issue":"8","key":"2019112612102186900_b16-0330032","first-page":"841","article-title":"Prostacyclin administration errors in pulmonary arterial hypertension patients admitted to hospitals in the United States: a national survey","volume":"19","author":"Kingman","year":"2009","journal-title":"Int J Heart Lung Transplant"},{"key":"2019112612102186900_b17-0330032","unstructured":"Patient Safety Solutions. Vol 1, solution 5: Control of concentrated electrolyte solutions. World Health Organization. http:\/\/www.who.int\/patientsafety\/solutions\/patientsafety\/PS-Solution5.pdf. Published May 2007. Accessed July 5, 2013."},{"key":"2019112612102186900_b18-0330032","unstructured":"National Coordinating Council for Medication Error Reporting and Prevention. Recommendations from the National Coordinating Council for Medication Error Reporting and Prevention. http:\/\/www.ashp.org\/DocLibrary\/BestPractices\/MedMisEndNCCMERP.aspx. Published 1999. Accessed July 5, 2013."},{"key":"2019112612102186900_b19-0330032","first-page":"1948","article-title":"Similar drug names a risky prescription","volume":"91","author":"Hamptom","year":"2004","journal-title":"JAMA"},{"key":"2019112612102186900_b20-0330032","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/jama.288.4.501","article-title":"What practices will most improve safety? Evidence-based medicine meets patient safety","volume":"288","author":"Lucian","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"2019112612102186900_b21-0330032","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00001786-200407000-00007","article-title":"Nurse perceptions of medication errors: what we need to know for patient safety","volume":"19","author":"Mayo","year":"2004","journal-title":"J Nurs Care Qual"},{"issue":"3\u20134","key":"2019112612102186900_b22-0330032","first-page":"111","article-title":"Nurses\u2019 perceptions of medication errors","volume":"22","author":"Karadeniz","year":"2002","journal-title":"Int J Clin Pharmacol Res"},{"issue":"2","key":"2019112612102186900_b23-0330032","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1741-6787.2009.00151.x","article-title":"Work interruptions and their contribution to medication administration errors: an evidence review","volume":"6","author":"Biron","year":"2009","journal-title":"Worldviews Evid Based Nurs"},{"issue":"12","key":"2019112612102186900_b24-0330032","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00005110-200212000-00008","article-title":"The impact of staffing on patient outcomes across specialty units","volume":"32","author":"Whitman","year":"2002","journal-title":"J Nurs Adm"},{"issue":"3","key":"2019112612102186900_b25-0330032","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3928\/0022-0124-20050501-08","article-title":"Innovative approaches to reducing nurses\u2019 distractions during medication administration","volume":"36","author":"Pape","year":"2005","journal-title":"J Contin Educ Nurs"},{"issue":"2","key":"2019112612102186900_b26-0330032","first-page":"77","article-title":"Administering restricted medications in hospital: the implications and costs of using two nurses","volume":"12","author":"Kruse","year":"1992","journal-title":"Aust Clin Rev"},{"issue":"1","key":"2019112612102186900_b27-0330032","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00005110-200401000-00009","article-title":"Nurse staffing models, nursing hours, and patient safety outcomes","volume":"34","author":"McGillis","year":"2004","journal-title":"J Nurs Adm"},{"issue":"5","key":"2019112612102186900_b28-0330032","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/qshc.2005.017608","article-title":"Using the Internet to deliver education on drug safety","volume":"15","author":"Franklin","year":"2006","journal-title":"Qual Safe Health Care"},{"issue":"4","key":"2019112612102186900_b29-0330032","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3928\/00220124-20070701-04","article-title":"A medication safety education program to reduce the risk of harm caused by medication errors","volume":"38","author":"Dennison","year":"2007","journal-title":"J Contin Educ Nurs"},{"issue":"9","key":"2019112612102186900_b30-0330032","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1007\/s00134-010-1860-2","article-title":"Impact of simulation-based learning on medication error rates in critically ill patients","volume":"36","author":"Ford","year":"2010","journal-title":"Intensive Care Med"},{"issue":"1","key":"2019112612102186900_b31-0330032","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00006216-200501000-00013","article-title":"Intravenous medication safety system averts high-risk medication errors and provides actionable data","volume":"29","author":"Fields","year":"2005","journal-title":"Nurs Adm Q"},{"issue":"3","key":"2019112612102186900_b32-0330032","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/01.CCM.0000155912.73313.CD","article-title":"A controlled trial of smart infusion pumps to improve medication safety in critically ill patients","volume":"33","author":"Rothschild","year":"2005","journal-title":"Crit Care Med"},{"issue":"6","key":"2019112612102186900_b33-0330032","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1945-1474.2004.tb00527.x","article-title":"Using bar-code point-of-care technology for patient safety","volume":"26","author":"Anderson","year":"2004","journal-title":"J Healthc Qual"},{"issue":"2","key":"2019112612102186900_b34-0330032","first-page":"103","article-title":"Bar-code technology for medication administration: medication errors and nurse satisfaction","volume":"18","author":"Fowler","year":"2009","journal-title":"Medsurg Nurs"},{"issue":"8","key":"2019112612102186900_b35-0330032","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1365-2702.2006.01398.x","article-title":"Patient self-medication: a change in hospital practice","volume":"15","author":"Grantham","year":"2006","journal-title":"J Clin Nurs"},{"issue":"4","key":"2019112612102186900_b36-0330032","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/193229681000400415","article-title":"Outpatient-to-inpatient transition of insulin pump therapy: successes and continuing challenges","volume":"4","author":"Nassar","year":"2010","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"2019112612102186900_b37-0330032","first-page":"101","article-title":"Patient safety challenges in treprostinil therapy","volume":"17","author":"Roncesvalles","year":"2008","journal-title":"Medsurg Nurs"}],"container-title":["Critical Care Nurse"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/aacnjournals.org\/ccnonline\/article-pdf\/33\/5\/32\/113649\/32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/aacnjournals.org\/ccnonline\/article-pdf\/33\/5\/32\/113649\/32.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T17:43:53Z","timestamp":1574790233000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacnjournals.org\/ccnonline\/article\/33\/5\/32\/20412\/Safety-Recommendations-for-Administering"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,1]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10,1]]}},"URL":"https:\/\/doi.org\/10.4037\/ccn2013608","relation":{},"ISSN":["0279-5442","1940-8250"],"issn-type":[{"value":"0279-5442","type":"print"},{"value":"1940-8250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,1]]}}}